plumbagin has been researched along with Cancer of Head in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Q; Liu, C; Qiu, J; Xin, Y | 1 |
| Chang, YJ; Chen, L; Tsao, YC; Wang, CH | 1 |
| He, ZX; Pan, ST; Qin, Y; Qiu, JX; Wang, D; Yang, T; Yang, YX; Zhang, X; Zhou, SF; Zhou, ZW | 1 |
3 other study(ies) available for plumbagin and Cancer of Head
| Article | Year |
|---|---|
Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Head and Neck Neoplasms; Humans; Mice; Tongue Neoplasms; Transcription Factors; Tumor Microenvironment | 2023 |
Discovery of Isoplumbagin as a Novel NQO1 Substrate and Anti-Cancer Quinone.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Survival; Head and Neck Neoplasms; HeLa Cells; Humans; Mice; NAD(P)H Dehydrogenase (Quinone); Naphthoquinones; PC-3 Cells; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays | 2020 |
Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Line, Tumor; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; G2 Phase Cell Cycle Checkpoints; Head and Neck Neoplasms; Humans; Naphthoquinones; Neoplastic Stem Cells; NF-E2-Related Factor 2; Oxidative Stress; Protein Interaction Maps; Protein Transport; Proteomics; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tongue Neoplasms | 2015 |